Clinical Trials Browser

Phase 2 × OTHER_GOV × Classical hematology × Clear all

NCT07187908 2025-09-23

Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FN

Phase 2 Recruiting

Classical hematology

Primary/Secondary Prevention

NCT06898983 2025-03-28

Efficacy and Safety Study of Romiplostim N01 for Cancer Treatment-induced Thrombocytopenia (CTIT) in the Treatment of Leukemia

Phase 2 Not yet recruiting

Classical hematology

Cancer Treatment-induced Thrombocytopenia (CTIT)

NCT02628860 2020-04-28

FCM

Phase 2 Completed

Classical hematologyGastrointestinal

Anemia, Pancreatic Neoplasms